Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Qiagen N.V.
(NY:
QGEN
)
42.76
+0.01 (+0.02%)
Streaming Delayed Price
Updated: 1:02 PM EDT, Mar 28, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
627,571
Open
42.54
Bid (Size)
42.75 (1)
Ask (Size)
42.77 (3)
Prev. Close
42.75
Today's Range
42.43 - 42.91
52wk Range
34.74 - 47.70
Shares Outstanding
227,985,334
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Diagnostic Firm Qiagen's Q3 Earnings: Analyst Says Annual Projections Attainable Despite Macro Trends
October 31, 2023
Qiagen NV's (NASDAQ: QGEN) Q3 net sales of $470 million at constant exchange rates (CER) for Q3 2023 were above the outlook for at least $465 million CER, driven by 5% CER growth in the
Via
Benzinga
QIAGEN and Myriad Genetics partner to advance companion diagnostics development for cancer
October 26, 2023
From
Myriad Genetics, Inc.
Via
GlobeNewswire
Performance
YTD
-2.04%
-2.04%
1 Month
-1.84%
-1.84%
3 Month
-1.66%
-1.66%
6 Month
+8.34%
+8.34%
1 Year
-6.52%
-6.52%
More News
Read More
Biden Administration Restarts Distribution Of Free At Home COVID-19 Tests, After Suspending For Year
September 21, 2023
Via
Benzinga
Exposures
COVID-19
Will Chart Analysts Notice Bad Omen on Qiagen's Chart
April 11, 2023
Via
Benzinga
Earnings Scheduled For February 6, 2024
February 06, 2024
Via
Benzinga
Earnings Preview: Qiagen
February 05, 2024
Via
Benzinga
Goldman Sachs Upgrades Twist Bioscience, Says Express Genes Launch Will Drive Margin Expansion
January 17, 2024
Via
Benzinga
Qiagen's Health Odyssey: Expanding In Riyadh And Partnering In Public Projects
January 03, 2024
Via
Benzinga
Qiagen Has Steady Income And Defensive Growth Potential, Goldman Sachs Upgrades Stock
December 07, 2023
Via
Benzinga
Where Qiagen Stands With Analysts
December 07, 2023
Via
Benzinga
These Companies Helped The German DAX Index Hit Its All-time High
December 06, 2023
Via
Talk Markets
Analyst Expectations for Qiagen's Future
November 02, 2023
Via
Benzinga
Preview: Qiagen's Earnings
October 27, 2023
Via
Benzinga
Earnings Scheduled For October 30, 2023
October 30, 2023
Via
Benzinga
Analyst Expectations for Qiagen's Future
October 17, 2023
Via
Benzinga
Stocks That Hit 52-Week Lows On Tuesday
September 19, 2023
Via
Benzinga
Bio-Rad and QIAGEN Announce Patent Settlement and Cross-Licensing Agreement
July 26, 2023
From
Bio-Rad Laboratories, Inc.
Via
Business Wire
Benzinga's Top Ratings Upgrades, Downgrades For September 12, 2023
September 12, 2023
Via
Benzinga
The 3 Most Promising Biotech Stocks to Buy Now
March 21, 2023
Via
InvestorPlace
QIAGEN Announces Form 20-F Annual Report Filing for 2022 Results
March 13, 2023
From
QIAGEN N.V.
Via
Business Wire
QIAGEN and Servier Partner to Develop Companion Diagnostic for Acute Myeloid Leukemia (AML) Therapy Drug
March 09, 2023
From
QIAGEN N.V.
Via
Business Wire
QIAGEN and SOPHiA GENETICS Forge Partnership to Combine Strengths in Next-Generation Sequencing
March 01, 2023
From
QIAGEN N.V.
Via
Business Wire
QIAGEN’s tuberculosis blood test QuantiFERON-TB Gold Plus gains CE-marking under new EU IVDR framework
February 14, 2023
From
QIAGEN N.V.
Via
Business Wire
QIAGEN Exceeds Outlook for Fourth Quarter and Full-Year 2022 With 14% CER Sales Growth in FY 2022 From Non-COVID Product Groups
February 07, 2023
From
QIAGEN N.V.
Via
Business Wire
Genetic Technologies Shares Jump After Strategic Alliance With Qiagen
February 01, 2023
Via
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.